The effects of sub-optimal sample handling on multiple complement measurements: Is there a potential signature of mishandling?

Ashley Frazer-Abel, Director at Exsera BioLabs (University of Colorado; CO, USA). “To my work in complement immuno-biology, I brought my PhD in biochemistry and post docs in immunology. After initially working in clinical immunology, I expanded my focus to include work to support FDA IND enabling studies. At the time I started working in complement and non-clinical and clinical trials, most of the work we did was related to immuno-toxicology and the potential for adverse complement responses to the new biological classes of drugs. It is exciting to now be involved in testing for diagnosis and efficacy. My continued work...